Identification of genes, including the gene encoding p27Kip1, regulated by serine 276 phosphorylation of the p65 subunit of NF-κB

Cancer Letters

Volumn 275, Issue 1, 2009, Pages 139-149

  Prasad, Ratna Chakraborty ^b   Wang, Xiaohui L ^b   Law, Brian K ^a   Davis, Bradley ^a   Green, Gail ^a   Boone, Braden ^c   Sims, Lauren ^c   Law, Mary ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

NF B; p27; p65; Serine 276; TNF

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P27; SERINE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION; VIRUS INFECTION;

ADENOVIRIDAE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; RNA, MESSENGER; SERINE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58549114670     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.007     Document Type: Article

References (37)

1. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
2. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
3. O'Shea J.M., and Perkins N.D. Regulation of the RelA (p65) transactivation domain. Biochem. Soc. Trans. 36 (2008) 603-608
4. Zhong H., Voll R.E., and Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1 (1998) 661-671
5. Okazaki T., Sakon S., Sasazuki T., Sakurai H., Doi T., Yagita H., Okumura K., and Nakano H. Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300 (2003) 807-812
6. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., and Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22 (2003) 1313-1324
7. Anrather J., Racchumi G., and Iadecola C. Cis-acting, element-specific transcriptional activity of differentially phosphorylated nuclear factor-kappa B. J. Biol. Chem. 1 (2005) 244-252
8. Hiroi M., and Ohmori Y. The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-kappa B for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-gamma gene. J. Biol. Chem. 278 (2003) 651-660
9. Sheppard K.A., Rose D.W., Haque Z.K., Kurokawa R., McInerney E., Westin S., Thanos D., Rosenfeld M.G., Glass C.K., and Collins T. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell. Biol. 19 (1999) 6367-6378
10. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., and Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94 (1997) 2927-2932
11. Vanden Berghe W., De Bosscher K., Boone E., Plaisance S., and Haegeman G. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274 (1999) 32091-32098
12. Shumilla J.A., Broderick R.J., Wang Y., and Barchowsky A. Chromium(VI) inhibits the transcriptional activity of nuclear factor-kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein. J. Biol. Chem. 274 (1999) 36207-36212
13. Waltner-Law M., Daniels M.C., Sutherland C., and Granner D.K. NF-kappa B inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene. J. Biol. Chem. 275 (2000) 31847-31856
14. Nowak D.E., Tian B., Jamaluddin M., Boldogh I., Vergara L.A., Choudhary S., and Brasier A.R. RelA ser276 phosphorylation is required for activation of a subset of NF-κB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol. Cell. Biol. 28 (2008) 3623-3638
15. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B.A. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95 (1998) 2509-2514
16. Law B.K., Norgaard P., Gnudi L., Kahn B.B., Poulson H.S., and Moses H.L. Inhibition of DNA synthesis by a farnesyltransferase inhibitor involves inhibition of the p70(s6k) pathway. J. Biol. Chem. 274 (1999) 4743-4748
17. Law B.K., Chytil A., Dumont N., Hamilton E.G., Waltner-Law M.E., Aakre M.E., Covington C., and Moses H.L. Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Mol. Cell. Biol. 22 (2002) 8184-8198
18. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
19. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
20. Wang D., and Baldwin Jr. A.S. Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273 (1998) 29411-29416
21. Sakurai H., Chiba H., Miyoshi H., Sugita T., and Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274 (1999) 30353-30356
22. Sakurai H., Suzuki S., Kawasaki N., Nakano H., Okazaki T., Chino A., Doi T., and Saiki I. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278 (2003) 36916-36923
23. Wang D., Westerheide S.D., Hanson J.L., and Baldwin Jr. A.S. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275 (2000) 32592-32597
24. Jiang X., Takahashi N., Matsui N., Tetsuka T., and Okamoto T. The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J. Biol. Chem. 278 (2003) 919-926
25. Duran A., Diaz-Meco M.T., and Moscat J. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J. 22 (2003) 3910-3918
26. Buss H., Dorrie A., Lienhard Schmitz M., Frank R., Livingstone M., Resch K., and Kracht M. Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J. Biol. Chem. 48 (2004) 49571-49574
27. Hu J., Nakano H., Sakurai H., and Colburn N.H. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells. Carcinogenesis 10 (2004) 1991-2003
28. Claudio P.P., Russo G., Kumar C.A., Minimo C., Farina A., Tutton S., Nuzzo G., Giuliante F., Angeloni G., Maria V., Vecchio F.M., Campli C.D., and Giordano A. PRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance. Clin. Cancer Res. 10 (2004) 3509-3517
29. Tai D.I., Tsai S.L., Chang Y.H., Huang S.N., Chen T.C., Chang K.S., and Liaw Y.F. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89 (2000) 2274-2281
30. Guo S.P., Wang W.L., Zhai Y.Q., and Zhao Y.L. Expression of nuclear factor-kappa B in hepatocellular carcinoma and its relation with the X protein of hepatitis B virus. World J. Gastroenterol. 7 (2001) 340-344
31. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., and Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
32. Futakuchi M., Ogawa K., Tamano S., Takahashi S., and Shirai T. Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma. Cancer Sci. 95 (2004) 18-24
33. Nan K.J., Jing Z., and Gong L. Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma. World J. Gastroenterol. 10 (2004) 1425-1430
34. Ito Y., Matsuura N., Sakon M., Miyoshi E., Noda K., Takeda T., Umeshita K., Nagano H., Nakamori S., Dono K., Tsujimoto M., Nakahara M., Nakao K., Taniguchi N., and Monden M. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology 30 (1999) 90-99
35. Hui A.M., Sun L., Kanai Y., Sakamoto M., and Hirohashi S. Reduced p27Kip1 expression in hepatocellular carcinomas. Cancer Lett. 132 (1998) 67-73
36. Tannapfel A., Grund D., Katalinic A., Uhlmann D., Kockerling F., Haugwitz U., Wasner M., Hauss J., ngeland K., and Wittekind C. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int. J. Cancer 89 (2000) 350-355
37. Best J.L., Amezcua C.A., Mayr B., Flechner L., Murawsky C.M., Emerson B., Zor T., Gardner K.H., and Montminy M. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc. Natl. Acad. Sci. USA 101 (2004) 17622-17627